US 11370764
RIP1 inhibitory compounds and methods for making and using the same
granted A61PA61P29/00A61P35/00
Quick answer
US patent 11370764 (RIP1 inhibitory compounds and methods for making and using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P37/02